GPD1L Antibodies

Santa Cruz Biotechnology offers a broad range of GPD1L monoclonal antibodies for research focused on understanding GPD1L's role in various biological processes. GPD1L monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). GPD1L, or glycerol-3-phosphate dehydrogenase 1-like, is a crucial enzyme involved in lipid metabolism and energy production. GPD1L plays a significant role in the regulation of cellular energy homeostasis and has been linked to various metabolic disorders. Research has shown that GPD1L influences cardiovascular health through its metabolic functions. Scientists studying GPD1L can gain valuable insights into cellular metabolism and energy regulation pathways. GPD1L research continues to reveal new connections between metabolism and disease progression. Understanding GPD1L function helps researchers explore potential therapeutic approaches for metabolic conditions. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of GPD1L's role in human health and disease.